Alkermes
Alkermes is a provider of innovative medicines that address the unmet needs and challenges of people living with debilitating diseases. As a fully integrated global biopharmaceutical company, Alkermes applies its scientific expertise, proprietary technologies, and global resources to develop products that are designed to make a meaningful difference in the way patients manage their disease.
Financial Data
-
31st Dec 18 Source: CRO
- €662.9 million turnover
-
-€145.7 million
profit - 361 employees
-
31st Dec 17 Source: Company
- €541.4 million turnover
-
-€146.6 million
profit - 2,000 employees
- 6 more years available »
Ranking
By Turnover
(€662.9 million)- 127th in Top Companies
- 17th in Health
- 16th in Pharma
By Employees
(361)- 444th in Top Companies
- 67th in Health
- 45th in Pharma
-
- 361
- €662.9 million
Employees
- Richard Pops CEO/Managing Director
Latest News
- 6:00am Retailers accused of ‘stealing business’ from rivals by flouting restrictions
- Oct 23 Goldman Sachs in talks to take over Blanchardstown shopping centre
- Oct 23 MEPs agree mandate on EU farming subsidies programme
- Oct 23 Irish banks push Iseq higher as Barclays results cheer investors
- Oct 23 Court told INM inspectors have formed views without all material they should have available